141 related articles for article (PubMed ID: 28733563)
1. Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients.
Devaraj NK; Mohamed M; Hussein N
Med J Malaysia; 2017 Jun; 72(3):157-164. PubMed ID: 28733563
[TBL] [Abstract][Full Text] [Related]
2. Necessity and concerns about lipid-lowering medical treatments and risk factors for non-adherence: A cross-sectional study in Palestine.
Shakarneh JK; Hallak HO; Awadallah HB; Al-Hamed DH; Khdour MR
Int J Clin Pract; 2020 Jul; 74(7):e13511. PubMed ID: 32279380
[TBL] [Abstract][Full Text] [Related]
3. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
[TBL] [Abstract][Full Text] [Related]
4. Adherence to lipid-lowering agents among 11,042 patients in clinical practice.
Wong MC; Jiang JY; Griffiths SM
Int J Clin Pract; 2011 Jul; 65(7):741-8. PubMed ID: 21676117
[TBL] [Abstract][Full Text] [Related]
5. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
Terebelo S; Markell M
Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
[TBL] [Abstract][Full Text] [Related]
7. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
[TBL] [Abstract][Full Text] [Related]
8. Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
Alfaifi AA; Lai L; Althemery AU
PLoS One; 2021; 16(8):e0255729. PubMed ID: 34352007
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study.
Awad A; Osman N; Altayib S
Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):350-355. PubMed ID: 28345729
[TBL] [Abstract][Full Text] [Related]
10. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting.
Stacy JN; Schwartz SM; Ershoff D; Shreve MS
Popul Health Manag; 2009 Oct; 12(5):241-54. PubMed ID: 19848566
[TBL] [Abstract][Full Text] [Related]
11. Factors of hyperlipidemia medication adherence in a nationwide health plan.
Wiegand P; McCombs JS; Wang JJ
Am J Manag Care; 2012 Apr; 18(4):193-9. PubMed ID: 22554007
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol lowering medication - patients' knowledge, attitudes and experiences.
Gialamas A; Aylward P; Vanlint S; Stocks NP
Aust Fam Physician; 2011 Jul; 40(7):519-22. PubMed ID: 21743861
[TBL] [Abstract][Full Text] [Related]
13. Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.
Nelson LA; Graham MR; Lindsey CC; Rasu RS
Psychosomatics; 2011; 52(4):310-8. PubMed ID: 21777713
[TBL] [Abstract][Full Text] [Related]
14. The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) survey for patients: results of a validation study.
Foley KA; Vasey J; Berra K; Alexander CM; Markson LE
J Cardiovasc Nurs; 2005; 20(1):35-42. PubMed ID: 15632811
[TBL] [Abstract][Full Text] [Related]
15. Adherence to lipid-lowering drug therapy among members of the Canadian Forces.
Ma J; Vaillancourt R; Bennett C
Mil Med; 2008 Jul; 173(7):666-70. PubMed ID: 18700601
[TBL] [Abstract][Full Text] [Related]
16. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications.
Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M
Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence perspectives in haemodialysis patients: a qualitative study.
Ghimire S; Castelino RL; Jose MD; Zaidi STR
BMC Nephrol; 2017 May; 18(1):167. PubMed ID: 28532480
[TBL] [Abstract][Full Text] [Related]
18. [Effects of changing the appearance of medications in safety and adherence in chronic patients over 65 years of age in primary care. CAMBIMED Study].
Arancón-Monge JM; de Castro-Cuenca A; Serrano-Vázquez Á; Campos-Díaz L; Rodríguez Barrientos R; Del Cura-González I; ;
Aten Primaria; 2020 Feb; 52(2):77-85. PubMed ID: 31481266
[TBL] [Abstract][Full Text] [Related]
19. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials.
Schedlbauer A; Schroeder K; Fahey T
Fam Pract; 2007 Sep; 24(4):380-7. PubMed ID: 17630270
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
